Cagrilintide vs semaglutide (Wegovy/Ozempic) Mechanism: Cagrilintide: Amylin receptor agonist Semaglutide: GLP-1 receptor agonist Different pathways Weight loss: Cagrilintide alone: 10-12% Semaglutide alone: 10-15% Similar efficacy monotherapy Gastric emptying: Cagrilintide: Very strong delay Semaglutide: Moderate delay Cagrilintide more powerful Side effects: Cagrilintide: More GI effects (stronger gastric slowing) Semaglutide: Moderate GI effects Cagrilintide harder to tolerate for some Availability: Cagrilintide: Investigational (not approved) Semaglutide: FDA approved, widely available Semaglutide easier to obtain currently Combination potential: Synergistic together (CagriSema) 15-25% weight loss combined Best of both mechanisms Verdict: Similar monotherapy efficacy, but combine for maximum results
Clinical trials measuring serum IGF-1 in approximately 900 participants found zero change with AOD-9604 treatment at all doses tested
The clinician's job is to hold that line and to refer questions of selection, evidence interpretation, and compliant sourcing to structured education rather than forum threads
Anabolic steroids (exogenous [from outside the body] testosterone and testosterone-like drugs) used by some athletes and body builders suppress hormonal signals from the brain that are needed to stimulate normal sperm production and maturation
Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis. J Physiol Paris 93(4):315321
This "builds over time" narrative is community-reported and aligns loosely with the synaptogenesis framing, but it is anecdote layered on a mechanism story whose foundational papers were retracted
